These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1973937)

  • 1. Neuroendocrine effects of azapirones.
    Cowen PJ; Anderson IM; Grahame-Smith DG
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):21S-25S. PubMed ID: 1973937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.
    Yocca FD
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):6S-12S. PubMed ID: 1973941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of gepirone on neuroendocrine function and temperature in humans.
    Anderson IM; Cowen PJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1990; 100(4):498-503. PubMed ID: 2157231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers.
    Walsh AE; Ware CJ; Cowen PJ
    Psychopharmacology (Berl); 1991; 105(4):568-72. PubMed ID: 1663254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of azapirones on serotonin1A neurons of the dorsal raphe.
    Matheson GK; Pfeifer DM; Weiberg MB; Michel C
    Gen Pharmacol; 1994 Jul; 25(4):675-83. PubMed ID: 7958728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists.
    Li Q; Rittenhouse PA; Levy AD; Alvarez Sanz MC; Van de Kar LD
    Neuropharmacology; 1992 Oct; 31(10):983-9. PubMed ID: 1359439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
    Cleare AJ; Forsling M; Bond AJ
    Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
    Gilbert F; Dourish CT
    Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
    Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
    Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear.
    Rittenhouse PA; Bakkum EA; O'Connor PA; Carnes M; Bethea CL; van de Kar LD
    Brain Res; 1992 May; 580(1-2):205-14. PubMed ID: 1354556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
    Gilbert F; Brazell C; Tricklebank MD; Stahl SM
    Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.
    McAllister-Williams RH; Massey AE
    Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated doses of azapirones on rat brain 5-HT1A receptors and plasma corticosterone levels.
    Matheson GK; Raess BU; Tunnicliff G
    Gen Pharmacol; 1996 Mar; 27(2):355-61. PubMed ID: 8919656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.